AbbVie

AbbVie is a biotech business focusing on pharmaceutical, biologic, and medical device research, development, and manufacturing. The company's primary emphasis is the discovery of medications to treat diseases such as cancer, immune-mediated diseases, neurological disorders, and chronic kidney disease.

AbbVie was created in 2013 as a spinoff from the healthcare corporation Abbott Laboratories. Since then, the company has grown tremendously and has established itself as a market leader in the biotech industry.

AbbVie's product portfolio includes some of the world's best-selling medications, including Humira, a treatment for autoimmune illnesses like rheumatoid arthritis, psoriasis, and Crohn's disease. In addition, the company has a pipeline of new medications in development that target a variety of ailments.

As of May 2023, AbbVie is a profitable firm with a market valuation of roughly $190 billion. In 2022, the company's revenue was $59.7 billion, with a net profit of $13.6 billion.

AbbVie is dedicated to being a good corporate citizen and has measures in place to promote sustainability, social responsibility, and ethical business practices. The corporation also participates in charitable efforts, emphasizing expanding access to healthcare and education.

AbbVie has a reputation for being a nice employer and has been named one of the top biotech firms to work for. The organization values diversity, inclusivity, and teamwork and offers its employees possibilities for personal and professional development.

Founded: 2013

Headquarters: North Chicago, Illinois, U.S.

Website: https://www.abbvie.com/